The Efficacy of Reminders to Complete HPV Series (ICHAT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01731496|
Recruitment Status : Completed
First Posted : November 21, 2012
Last Update Posted : February 6, 2015
|Condition or disease||Intervention/treatment|
|Completion of Three Dose Series of HPV Improvement in Vaccine Intervals Between HPV Doses||Other: Telephone reminder Other: Text Message reminder|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||749 participants|
|Intervention Model:||Factorial Assignment|
|Primary Purpose:||Health Services Research|
|Official Title:||Improving Communication and Health for Adolescents With Technology - Implementation of Immunization Strategy|
|Study Start Date :||April 2012|
|Primary Completion Date :||May 2014|
|Study Completion Date :||October 2014|
Experimental: Telephone reminder
Telephone message reminder to parents of adolescents whose child is due for a 2nd or 3rd dose of HPV vaccine.
Other: Telephone reminder
One week prior to when a child is due for either their 2nd or 3rd HPV vaccine, their parent will receive a telephone reminder to call to make an appointment to receive their next dose. A total of 3 reminders will be sent.
Experimental: Text Message reminder
Text message reminder to parents of adolescents whose child is due for a 2nd or 3rd dose of HPV vaccine.
Other: Text Message reminder
One week prior to when a child is due for either their 2nd or 3rd HPV vaccine, their parent will receive a text message reminder to call to make an appointment to receive their next dose. A total of 3 reminders will be sent.
|No Intervention: Control: Telephone|
|No Intervention: Control: Text Message|
- HPV completion rate [ Time Frame: One Year ]Post intervention HPV vaccination rates will be summarized by intervention group with frequencies and proportions, and will be compared between groups using chi square or Fisher's exact test as appropriate
- HPV Dosing Intervals [ Time Frame: One Year ]Dosing intervals will be summarized by group with mean, median, standard deviation and will be compared between groups using a two sample t-test.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01731496
|United States, New York|
|Culver Medical Group|
|Rochester, New York, United States, 14609|
|Highland Family Medicine|
|Rochester, New York, United States, 14620|
|Strong Pediatric Practice|
|Rochester, New York, United States, 14642|
|Principal Investigator:||Cynthia Rand, MD, MPH||University of Rochester|